Vitamin B12 (Cobalamin).

B12 is the cofactor for methionine synthase, the enzyme that transfers folate's methyl group onto homocysteine to rebuild methionine, so the two vitamins continuously recycle each other through the methylation cycle. Folate can normalize the red blood cell picture on its own while B12's separate role in nerve function still goes unmet, which is why the pair is kept together rather than one swapped for the other.

B12 and folate remethylate homocysteine back to methionine, while vitamin B6 in its active PLP form drives the parallel route that clears homocysteine onward through cystathionine, so the three cofactors together cover both exits from the same intermediate. This settled biochemistry is why B6, folate, and B12 are the standard trio behind normal homocysteine metabolism.

Building a red blood cell takes both roles at once: B12 with folate supplies the DNA building blocks so the precursor cells can divide and mature, while iron makes the hemoglobin that fills them. Because neither can cover the other's job, the two are combined to support normal red blood cell formation.

Methionine synthase reductase is an FAD enzyme that re-reduces the cobalamin cofactor after oxidation, so riboflavin status sets how well the cobalamin enzyme keeps turning over. Riboflavin is a required partner in that cycle.

Cobalamin accepts the methyl group from 5-methyltetrahydrofolate and passes it to homocysteine. Without cobalamin the folate pool accumulates in the methyl form and cannot re-enter the one-carbon cycle.

Betaine donates a methyl group to homocysteine through BHMT, a route independent of folate and cobalamin. The two pathways converge on the same substrate, which is why they are formulated together.

Methionine formed by the cobalamin-dependent step is converted to SAM, the main cellular methyl donor. SAM concentrations feed back on the same cycle.

Choline oxidises to betaine and supplies the same methyl pool that the cobalamin and folate route serves, so the two are interchangeable to a degree. Supply of one spares the other.

Adenosylcobalamin serves methylmalonyl-CoA mutase in mitochondria while methylcobalamin serves cytosolic methylation. Carrying both coenzyme forms covers the two cobalamin-dependent enzymes.

The ileal cubam receptor binds the intrinsic factor and cobalamin complex only in the presence of calcium ions. Calcium availability is therefore part of the absorption step itself.

Cobalamin-dependent mutase clears propionyl-CoA while carnitine transports and buffers the same acyl groups as acylcarnitines. Both act on one acyl-CoA pool.

High ascorbate concentrations reduce cobalamin in solution and generate inactive analogues. Dosing a large ascorbate product apart from cobalamin avoids the loss.

Cobalamin in food is bound to protein and needs gastric acid plus pepsin to be liberated before it can be picked up by the binding proteins that carry it onward. Reduced gastric acidity leaves more of the food bound fraction unreleased. Crystalline cobalamin in a supplement is already free, so this applies to the diet alongside it.

Pepsin cleaves the proteins holding cobalamin in food, which is the first requirement of the absorption cascade. Every later step depends on it. It is upstream physiology rather than a tested combination.

Cobalamin bound to haptocorrin in the stomach must be released so intrinsic factor can take it, and pancreatic proteases perform that degradation. Low pancreatic output stalls the handover even when intrinsic factor is plentiful. Standard gastrointestinal physiology.

Betaine homocysteine methyltransferase is a zinc dependent enzyme, and zinc also participates in the methyl transfer chemistry of cobalamin dependent methyltransferases. Zinc and cobalamin therefore act on the same reaction from different positions. The relationship is enzymology; no human combination trial is cited.

Methionine synthase uses cobalamin to convert homocysteine back into methionine, so methionine is the direct product of the cobalamin dependent step. Supplying methionine also increases homocysteine downstream, since homocysteine is what methionine becomes after donating its methyl group. The two sit on opposite ends of the same cycle.

Making creatine in the body consumes a large share of available S-adenosylmethionine at the guanidinoacetate methylation step. Supplying creatine reduces that demand and spares methyl groups whose supply depends partly on the cobalamin dependent route. The mechanism is well described; the size of the effect in a person is not settled here.

Glycine N-methyltransferase discards surplus methyl groups by methylating glycine, which sets the ceiling on cellular methylation potential from the other side. Cobalamin sits on the supply side. Together they describe balance rather than accumulation.

Serine gives up its third carbon to tetrahydrofolate, producing the methylene folate that is reduced to the 5-methyl form cobalamin then uses. Without that donation, methionine synthase has no methyl group to transfer. Core one carbon biochemistry.

Homocysteine can be remethylated either by the folate and cobalamin dependent enzyme or by betaine derived from choline. Adequate choline containing phospholipid spares the cobalamin route, and the same is true in the other direction. This is one of the better characterised nutrient overlaps in methylation.

The liver makes some of its phosphatidylcholine by methylating phosphatidylethanolamine using S-adenosylmethionine, and that route matters for exporting long chain fats. Cobalamin feeds the methyl supply behind it. Mechanistic linkage only; no cited trial pairs the two.

Ample folic acid can keep red cell size normal while cobalamin status stays low, because folate covers the DNA synthesis step that cobalamin would otherwise gate. That makes cell size a less informative marker, and a marker is not an outcome. Methylmalonic acid does not behave that way and remains informative.

Copper dependent ferroxidases move iron to where haem is assembled, placing copper alongside cobalamin in normal red cell production. The overlap comes from nutrient biochemistry rather than a combination trial. Treated at Promising for that reason.

When cobalamin repletion restarts brisk cell production, potassium moves from serum into the newly formed cells and serum potassium can fall. This is watched in the first days of vigorous repletion. It is a physiological consequence to know about, not a benefit of combining the two.

Cobalamin entering a cell is reduced and passes through a glutathionylcobalamin intermediate before it is fitted with a methyl or adenosyl group. Cysteine supply from NAC feeds the thiol pool involved. Cell biochemistry, with no dosing benefit implied.

Methylcobalamin is one of the two active cofactor forms the body assembles from whatever cobalamin arrives. Cells dealkylate and reduce incoming cobalamin, then methylate it for methionine synthase or adenosylate it for the mitochondrial mutase. Supplying a preformed form enters that same processing route rather than bypassing it.

Hydroxocobalamin carries a hydroxyl group on the cobalt and is one of the naturally circulating forms; it feeds the same intracellular dealkylation and reassembly route as any other cobalamin. Its binding characteristics to plasma carrier proteins differ from the cyano form. No ranking between forms is offered here.

Cyanocobalamin carries a cyanide ligand introduced during purification, and cells must remove that ligand before assembling either active cofactor. It is the most crystallographically stable form and the one used in most fortification. A review of naturally occurring versus laboratory produced forms describes these differences without settling a preference.

Cobalt sits at the centre of the corrin ring and is the atom that makes the reversible carbon to metal bond possible. Human metabolism cannot build the ring, so dietary cobalt does not become cobalamin in people; only the microbes that synthesise it use cobalt that way. This is a structural relationship, not a reason to take cobalt.

Some gut bacteria synthesise corrinoids and others compete for them, and much of what colonic bacteria produce sits distal to the ileal absorption site. Whether a given strain adds to or draws from host cobalamin availability is unresolved. Listed at Early for that reason.

An oral preparation combining alpha lipoic acid with a B complex containing cobalamin has been assessed for effect and tolerability. The cobalamin contribution cannot be separated out in that design. Read it as evidence about the combination.

Propionyl-CoA carboxylase uses biotin to make the methylmalonyl-CoA that the adenosylcobalamin dependent mutase then rearranges. The two cofactors run consecutive steps in a short pathway. Neither substitutes for the other.